Zenith Drugs IPO Date, GMP, Review, Price, Details

The Zenith Drugs IPO has begun on 19-February-2024. It will close on 22-February-2024. The Total IPO Size is 40.68 Crores. The company set its IPO price is 79 Rs Per Share. Basically, There are three basic categories in Zenith Drugs IPO Subscription 1) QIB 2) Retail Individual Investors (RIIs) 3) NII.

Zenith Drugsare a pharmaceutical manufacturing and trading company based out from Indore.

The company is in the process of setting up a new manufacturing facility in Village Muradpura, Depalpur, Indore, Madhya Pradesh.

Zenith engages in third-party manufacturing, also known as white label manufacturing, for esteemed pharma companies such as Ajanta Pharma, Bio Medical Laboratories, Zest Pharma, and many others.

The global footprint extends to countries such as 1. Costa Rica in Central America and the Caribbean and Pacific regions, 2. Malawi, Mauritius, Mozambique, Sudan, and Tanzania. 3. Bhutan and Cambodia in Southeast Asia, 4. Tajikistan in the CIS region, and
5. Liberia, Sierra Leone, and Conakry in FWA.

Zenith offers a wide range of formulations in various forms such as:

a) Gas Pipeline Projects
b) Liquid Orals
c) Ointments
d) Liquid Externals
e) Capsules

Check :- Upcoming SME IPO 2024

Zenith Drugs IPO Promotor Holding

Mr. Sandeep Bhardwaj, Mr. Bhupesh Soni and Mr. Ajay Singh Dassundi are the promoters of the company.

Zenith Drugs IPO Date, Details & Price Band

IPO Opening Dates 19-February-2024
IPO Closing Dates 22-February-2024
Price Band 75-79 Rs
Fresh Issue 40.68 Crore
Total IPO size 40.68 Crore
Minimum bid (lot size) 1600 Shares
Face Value 10 INR Per Share
Listing On NSE SME

Zenith Drugs IPO Market Lot

The Zenith Drugs IPO minimum market lot is 1600 shares With 126,400 ₹ Amount per application.

Lot No of Shares Amount
Minimum 1 1600 126,400 Rs
Maximum 1 1600 126,400 Rs
S-HNI (Min) 2 3200 252,800 Rs

Restated Financial Record of the three year (Amt. in Lakhs)

Total Assets Total Revenue Profit After Tax
31-Mar-23 9,793.83 11,569.65 515.29
31-Mar-22 6,858.47 9,266.63 312.86

Zenith Drugs IPO GMP Grey Market Premium

Zenith Drugs IPO GMP Grey market premium has been started today. Check Latest Zenith Drugs IPO GMP Grey market premium, Kostak Rates and Subject to Sauda Price here.

Zenith Drugs IPO Prospectus

Zenith Drugs IPO
DRHP Download
RHP Download

Zenith Drugs IPO Reviews

IPOWala – Update Soon

Zenith Drugs IPO Form Download

Zenith Drugs IPO is available on NSE Website as well as on our Portal. Please click here Zenith Drugs IPO form Download.

Zenith Drugs IPO Allotment Date & Details

Allotment Date 23-February-2024
Initiation of refunds 26-February-2024
Transfer of shares to Demat accounts 26-February-2024
Listing Date 27-February-2024
Check Allotment Status Click here

Registrar of Zenith Drugs IPO

S6-2, 6th Pinnacle Business Park, Mahakali Caves Road, next to Ahura Centre, Andheri
East, Mumbai- 400093, Maharashtra, India
Tel No.: +91 – 22 – 6263 8200; Fax No.: +91 – 22 – 6263 8299
E-mail: [email protected]
Investor Grievance E-mail: [email protected]
Website: www.bigshareonline.com
Contact Person: Mr. Asif Sayyed
SEBI Registration No.: INR000001385

Zenith Drugs Contact Details

Zenith Drugs Limited
K. No. 72 / 5, Village Muradpura
NA Depalpur,
Phone: +91 8435501867
Email: [email protected]
Website: https://zenithdrugs.com/

Zenith Drugs IPO Lead Managers

Office No. 13, 1st Floor, New Bansilal Building, Raja Bahadur Mansion, 9-15, Homi Modi
Street, Fort, Mumbai– 400001, Maharashtra, India.
Tel No.: +91 96532 49863
Email: [email protected]
Website: www.gretexcorporate.com
Contact Person: Ms. Dimple Magharam Slun
SEBI Registration No: INM000012177
CIN: L74999MH2008PLC288128

Leave a Reply